Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine
 Disease Category: Colon Cancer
Location: United States, IL

Trial Information

MDA 2009-0288 Randomized Pilot Study of Oncologist Recommended Home-Based Exercise Program Versus Relaxation Training for Physical Functioning and Symptom Control in Patients With Unresectable Stage IV or Recurrent Colon Cancer

To evaluate the study feasibility of an oncologist recommended home-based exercise program vs relaxation training for physical functioning and symptom control, in terms of recruitment rate, patient retention, patient adherence to behavioral recommendations, and program and assessment implementation, in patients with stage IV or recurrent colon cancer.

To estimate the self-reported effect size of the exercise intervention on physical functioning in these patients

Patient Inclusion Criteria:

  • Diagnosis of colon cancer
  • Stage IV or recurrent disease
  • Unresectable disease

Patient Exclusion Criteria:

  • Not exercising at a moderate-vigorous intensity for ≥ 150 minutes per week or at a vigorous intensity for > 20 minutes on ≥ 3 days per week
  • No symptomatic bone metastase

Janeen V. Bazan, RN OCN BSN CCRP, Oncology Research Nurse Program Coordinator
Sherman Health
1425 North Randall Road
Elgin, IL 60123
Phone: 224-783-2907
Fax: 224-783-3071
Email: janeen.bazan@shermanhospital.org

View Map

Research Center Information: Sherman Health

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.